PE / VC
We are excited to share the first in what we expect will be an annual series of aMoon Impact reports. The purpose of this annual impact report is to share the progress our portfolio companies are making as they move along the path from innovation to commercialization to societal impact. aMoon was founded in 2017 to seize on the rapid convergence of healthcare and technology with the mission to Accelerate Cure. We have been built from the ground-up with this goal in mind. By partnering with outstanding entrepreneurs, management teams in Israel, and other global centers of innovation, we push ourselves to advance solutions that will help people live healthier, longer, and better lives. While our mission is first and foremost about cures, we recognize that the element of time is also critical and we view ourselves as agents to help bring revolutionary ideas to life – quickly.